Invention Grant
- Patent Title: Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent
-
Application No.: US15415112Application Date: 2017-01-25
-
Publication No.: US10584385B2Publication Date: 2020-03-10
- Inventor: Marie-Pierre Dube , Jean-Claude Tardif
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Priority: EP14179048 20140730
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883 ; A61K31/167
Abstract:
Genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator.
Public/Granted literature
- US20170233812A1 GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT Public/Granted day:2017-08-17
Information query
